Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Recruiting

Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan

NCT06829472

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: Rui Jin Hospital Shanghai, Shanghai Municipality, China

Zhaxin Hospital, Go Broad Health Care Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

HVA vs IA/DA or VA in the Treatment of ND HR-AML

NCT06810791

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia

NCT06802718

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments

NCT06764459

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola Bologna, Italy

View Trial Details

Recruiting

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

NCT06785077

Conditions: Adnexal Diseases, Anemia, Anemia, Refractory, +28 more
Locations: Istituto Europeo di Oncologia Milan, Italy

View Trial Details

Recruiting

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

NCT05601726

Conditions: Acute Myeloid Leukemia, Adult, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Hôpital de la Timone Marseille, France

Hôpital Saint-Louis Paris, France

Centre Hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Recruiting

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

NCT06783790

Conditions: AML (Acute Myelogenous Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

NCT05488548

Conditions: Bone Marrow Diseases, Castrate Resistant Prostate Cancer, Chronic Disease, +16 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

Mayo Clinic Florida Jacksonville, Florida, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Mayo Clinic Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia

NCT06762132

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia

NCT06760260

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions